Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi
Maria Assunta Rocca

Showing results (1051-1060 of 1,159) with videos related to

Pageof 116
Sort By:
Neurology|October 30, 2021
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS StudyMassimo Filippi, Paolo Preziosa, Alessandro Meani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Neuroimage. Clinical|April 21, 2021
Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated referencesAlexandra de Sitter, Jessica Burggraaff, Fabian Bartel, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Med (New York, N.Y.)|June 15, 2026
Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplantGiorgio Orofino, Angela Genchi, Maria Teresa Lupo Stanghellini, et al.
European Journal of Neurology|December 5, 2024
A common marker of affect recognition dysfunction in the FTD spectrum of disordersElisa Canu, Veronica Castelnovo, Edoardo Nicolò Aiello, et al.
Pageof 116

Showing results (1051-1060 of 1,159) with videos related to

Sort By:
Pageof 116
Neurology|October 30, 2021
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS StudyMassimo Filippi, Paolo Preziosa, Alessandro Meani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Neuroimage. Clinical|April 21, 2021
Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated referencesAlexandra de Sitter, Jessica Burggraaff, Fabian Bartel, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Med (New York, N.Y.)|June 15, 2026
Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplantGiorgio Orofino, Angela Genchi, Maria Teresa Lupo Stanghellini, et al.
European Journal of Neurology|December 5, 2024
A common marker of affect recognition dysfunction in the FTD spectrum of disordersElisa Canu, Veronica Castelnovo, Edoardo Nicolò Aiello, et al.
Pageof 116